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Cigarette smoking can impair pulmonary immune function, and hence influences the development of lung diseases. 
Interleukin-8 (IL-S) is a proinflammatory peptide and a potent chemotactic factor for neutrophils, and is produced 
by both immune and non-immune cells including monocytes and alveolar macrophages (AM). We investigated the 
effect of cigarette smoking on the secretion of IL-8 by human AM. The IL-8 concentration in bronchoalveolar 
lavage fluid (BALF) was much higher in smokers than in non-smokers (18.4 f 3.9 vs 4.1 * 1.0 pg ml- ‘; P<O.OOS). 
However, spontaneous IL-8 secretion by cultured AM was lower in smokers than in non-smokers (46.8 & 12.7 YS 
124.1 & 24.0 ng ml - ‘; P<O.Ol). When stimulated with lipopolysaccharide (LPS), AM from smokers secreted 
significantly less IL-8 than those from non-smokers at all tested concentrations of LPS. In contrast, the amount of 
IL-8 secreted by peripheral blood monocytes with or without LPS stimulation was comparable in smokers and 
non-smokers. These observations indicate that smoking decreases IL-8 secretion by AM, which may modify or 
decrease the inflammatory response in the lung. 
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Introduction 
Previous studies have shown that cigarette smoking 
can impair pulmonary immune function and develop lung 
diseases. For instance, the risk of lung cancer increases in 
direct proportion to the number of cigarettes smoked. 
Chronic obstructive pulmonary diseases, including chronic 
bronchitis and emphysema, and idiopathic pulmonary 
fibrosis (IPF) may be caused or exacerbated by cigarette 
smoking (l-3). Also, it has been demonstrated that 
cigarette consumption retards the development of several 
interstitial lung diseases. Inverse relationships have been 
observed between cigarette smoking and the development 
of hypersensitivity pneumonitis (4,5), or the specific serum 
antibodies that causes farmer’s lung (6,7). Similarly, the 
incidence of sarcoidosis is lower in a smoking cohort (8). 
Alveolar macrophages (AM) play a major role in 
smoking-induced alterations in immune function. Smoking 
reduces the cytotoxic activity and leukotriene B4 secretion 
by AM, and the antigen- or mitogen-stimulated T-cell 
proliferation through AM (9-l 1). Furthermore, smoking 
inhibits secretion of interleukin-1 (IL-l) and interleukin-6 
(IL-6) that are important for cell-mediated immune 
responses (12-14). Whereas all these effects of smoking 
increase susceptibility to infection, the resultant defect of 
Received 6 May 1997 and acccepted in revised form 16 February 
1998. 
Correspondence should be addressed to: N. Yamashita, First 
Department of Internal Medicine, Toyama Medical and Pharma- 
ceutical University, Sugitani, Toyama 930-0194, Japan. 
0954.6111/98/070922+06 $12.00/O 
the cell-mediated immunity in smokers may result in a 
lower incidence of immune-mediated lung diseases such as 
hypersensitivity pneumonitis. 
Interleukin-8 (IL-8), produced by monocytes, alveolar 
macrophages, endothelial cells, epithelial cells and fibro- 
blasts, is a proinflammatory peptide and a potent chemo- 
tactic factor for neutrophils (15-20). Induction of activating 
and chemotactic factors at the site of infection leads to the 
recruitment of leukocytes and the inflammatory response. 
In this regard, IL-8 may play an important role in the 
pathogenesis of various inflammatory lung diseases includ- 
ing adult respiratory distress syndrome (ARDS) (21) cystic 
fibrosis (22) and IPF (23). Recently Mio et al. (24) have 
demonstrated that cigarette smoke extract augmented IL-8 
release from cultured human bronchial epithelial cells. 
However, little is known about the effect of smoking on 
IL-8 production by AM. 
In this study we investigated the effect of cigarette 
smoking on the secretion of IL-8 by AM obtained from 
smokers and non-smokers. 
Methods 
STUDY POPULATION 
The subjects consisted of 20 healthy subjects (10 men and 
10 women), 10 non-smokers and 10 smokers. The mean 
smoking history of 10 smokers was 40.0 pack-years. 
The smokers were slightly older than the non-smokers 
(61.6 * 4.1 vs 51.8 * 6.2 yr), but the difference was not 
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statistically significant. The subjects had no history of upper 
respiratory tract infection in the preceding month before 
bronchoscopy. They had not taken corticosteroids, non- 
steroidal anti-inflammatory agents or antibiotics for 1 
month prior to the study period, and none were on these 
medications on a regular basis. Physical and bronchoscopic 
examination of all individuals revealed normal lungs and 
airways without evidence of bronchitis. All study subjects 
gave informed consent before the procedure. 
PREPARATION OF ALVEOLAR MACROPHAGES 
Bronchoalveolar lavage (BAL) was performed as pre- 
viously described (25). Briefly, the upper airways were 
anaesthetized with 2% lidocaine, and a fibre-optic broncho- 
scope was inserted into the tracheobronchial tree. The 
bronchoscope was placed in the wedged position in a 
sub-segmental bronchus of either the right middle or lingu- 
lar lobe, and three 50 ml aliquots of 0.9% saline solution 
were consecutively injected, and then removed by suction. 
The obtained bronchoalveolar lavage fluid (BALF) was 
filtered through sterile gauze, and centrifuged at 500 g for 
5 min. The recovered cells were washed three times with 
Hanks’ balanced salt solution (HBSS). AM were differen- 
tiated from lymphocytes and other BAL cells by morpho- 
logical criteria. Some 5 x lo5 viable AM ml- ’ were 
resuspended in the complete medium, i.e. RPMI-1640 
medium supplemented with 10% heat-inactivated bovine 
calf serum (ICN Biomedicals, Australia), 2 mM L-glutamine, 
12.5 mMmll ’ HEPES, 50 units ml-’ penicillin G and 
6Opg ml ~ ’ gentamicine, and were incubated for 2 h at 
37°C in humidified 5% CO,. Non-adherent cells were 
removed by washing with warm medium, and adherent cells 
were cultured for 24 h in complete medium. The super- 
natant was collected and stored at - 20°C until IL-8 assay. 
The reactivity of AM to Escherichiu coli (strain 055:B5)- 
derived lipopolysaccharide (LPS) was assessed by adding 
0.1 to 10 pug ml ~ ’ LPS. More than 95% of adherent cells 
were AM as assessed by Diff Quik ‘I, stains. 
ISOLATION OF PERIPHERAL BLOOD 
MONOCYTES 
Peripheral blood mononuclear cells were separated from 
heparinized venous blood by means of FicolllHypaque 
density gradient centrifugation. The cells were then 
depleted of non-adherent cells by plastic dish adherence as 
described previously (26,27). Briefly, peripheral blood 
mononuclear cells were washed three times with HBSS and 
were incubated in the complete medium for 2 h at 37°C in 
humidified 5% CO,. The cells were washed vigorously with 
warm medium. The remaining cells, referred to hereafter as 
peripheral blood monocytes, were resuspended in the com- 
plete medium at a concentration of 5 x lo5 cells ml - ‘, and 
incubated with LPS for 24 h. The supernatant was then 
collected and frozen at - 20°C until IL-8 assay. 
ELISA ASSAYS 
IL-8 was measured using the ELISA assay kit purchased 
from R & D Systems (Minneapolis, MN, U.S.A.). Cell free 
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TABLE 1. Characteristics of BALF 
Non-smokers Smokers 
(n= 10) (n= 10) 
Total cells ( x lo5 ml ~ ‘) 
Macrophages (‘Xl) 
Lymphocytes (‘%I) 
Neutrophils (o/o) 
Eosinophils (%) 
0.82 f 0.09 2.10 f 0.3s* 
93.1 * 1.5 92.2 f 2.3 
6.2 h 1.4 3.7 f 0.9 
0.6 zk 0.3 3.8 f 2.7 
0.1 Zt 0.1 0.4 f 0.3 
*P<O.Ol compared with non-smokers. 
Data are presented as mean f SE. 
culture supernatants were assayed for IL-S according to the 
manufacturer’s instructions. Samples were analysed with an 
automated ELISA plate reader. The assay sensitivity of this 
kit was approximately 3 pg ml ~ ‘. The total concentration 
of albumin in BALF was measured with a commercial 
assay kit (Nittobo, Tokyo, Japan). 
STATISTICAL ANALYSIS 
All assays were performed in triplicate. The data were 
expressed as mean * standard error of the mean. Differ- 
ences between the two groups means were compared by 
t-test. Simple linear correlation analysis (Pearson’s Y) 
was used for all correlation. P value less than 0.05 was 
considered as statistically significant. 
Results 
CHARACTERISTICS OF BALF 
The BALF obtained from the smokers contained about 2.5 
times as many cells as the BALF from the non-smokers did 
(Table 1). The percentage of neutrophils in BALF tended to 
be higher in smokers than in non-smokers, but the differ- 
ence did not reach statistical significance. The neutrophil 
concentration in BALF was higher in smokers than in 
non-smokers (6.44 f 4.3 vs 0.56 f 0.2 x lo3 ml- ‘), but the 
difference was not statistically significant. Cell viability was 
determined by trypan blue method and exceeded 90% in 
all cases. 
IL-8 CONCENTRATIONS IN BALF 
Since neutrophil concentrations in BALF of smokers 
tended to be higher than those of non-smokers, we investi- 
gated a potential role of IL-S released by AM for the local 
accumulation of neutrophils. The IL-8 concentration in 
BALF from smokers was much higher than that from 
non-smokers (18.4 f 3.9 vs 4.1 f I.0 pg ml ~ ‘; Fig. 1). 
However, the IL-8 concentration in BALF did not correlate 
with the number of neutrophils in BALF (r=0.34 , P=O.15) 
when smokers and non-smokers were studied together. 
As a reference for the IL-8 concentration, we measured 
the albumin concentration in BALF. The albumin 
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concentration in BALF was comparable in smokers and 
non-smokers (45.2 f 12.0 w 34.2 & 9.4pg ml- ‘), and the 
individual BALF IL-8 levels normalized by the BALF 
albumin concentrations also showed a significant difference 
between the two groups (0.69 f 0.18 YS 0.14 & 0.04 pg pg - ’ 
albumin). 
IL-8 SECRETION BY AM 
The time course of IL-8 production by AM was examined 
in three normal subjects (non-smokers). AM were stimu- 
lated with 1 ,ug ml - i of LPS and cultured for 48 h. The 
amount of IL-8 released by AM reached a plateau after 
24 h of incubation and remained constant thereafter (Fig. 
2). Accordingly, a 24-h time point was chosen for assessing 
IL-8 production by LPS stimulated AM. 
Contrary to our expectations, spontaneous in vitro IL-8 
secretion by AM was greater in non-smokers than in 
smokers (124.1 f 24.0 vs 46.8 f 12.6 ng ml- ‘; Fig. 3). Fur- 
thermore, LPS-stimulated AM from smokers secreted 
significantly less IL-8 than did AM from non-smokers at 
all tested LPS concentrations (Fig. 4). These phenomena 
continued from 6 to 72 h of incubation (data not shown). 
IL-8 SECRETION BY PERIPHERAL BLOOD 
MONOCYTES 
The IL-8 secretion by unstimulated peripheral blood mono- 
cytes from smokers and non-smokers was comparable as 
shown in Fig 5. LPS-stimulated monocytes from smokers 
tended to secrete less IL-8 than did those from non- 
smokers, but the difference was not statistically significant. 
Non-smokers Smokers 
FIG 1. The IL-8 concentrations in BALF from non- 
smokers and smokers. IL-8 was measured using an 
ELISA. Data are presented as mean * SE. *P<@OO5. 
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FIG 2. The time course of IL-8 secretion by alveolar mac- 
rophages in three normal subjects following incubation 
with lpgml-’ of LPS. Data are presented as mean f SE. 
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FIG 3. Spontaneous IL-8 secretion by alveolar macro- 
phages in non-smokers and smokers after 24 h culture. 
Data are presented as mean % SE. *P<O.Ol. 
Discussion 
The present study showed that cigarette smoking increased 
the total cell number in BALF, whereas there was no 
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FIG 4. Secretion of IL-8 by alveolar macrophages in non- 
smokers (a-) (n= 10) and smokers (a-) (n= 10) after 
24 h of culture with different concentrations of LPS. Data 
are presented as mean -+ SE. *P<O.Ol, **P~O.005, 
***P<O.OOl compared with smokers. 
difference in percentage of each cell population between 
smokers and non-smokers. It has been reported that in 
symptomatic smokers with productive cough, tobacco 
consumption increases the percentage of neutrophils in 
BALF (28). Since we studied asymptomatic smokers, the 
percentage of neutrophils in BALF was low compared with 
that of symptomatic smokers (28), and was similar to 
concentrations found in the non-smoking control subjects. 
Neutrophils rarely exist in the lung tissue or respiratory 
tract of healthy persons, and are thought to be attracted to 
the lung by neutrophil chemotactic factors. Several kinds of 
neutrophil chemoattractants have been identified in the 
respiratory tract. Among them, IL-8 is one of the most 
potent chemotactic factors for neutrophils in the airway. In 
this study we found that freshly isolated AM from smokers 
secreted smaller amounts of IL-8 than did those from 
non-smokers. 
AM are believed to be involved in the first line of defence 
against both viral and bacterial infections (29,30). These 
infections effectively induce the production of cytokines 
such as IL-l, tumour necrosis factor (TNF). IL-6, and IL-8 
(31). LPS is a potent, physiologically relevant stimulus that 
enhances the ability of AM to release these proinflamma- 
tory cytokines. Smoking is said to decrease IL-l and IL-6 
secretion by LPS-stimulated AM (12-14). However, little is 
known about the effect of cigarette smoking on IL-S 
production by AM. In the present study, we demonstrated 
400 
300 
-cc- 
E 
M 200 
2 
cc 
A 
100 
0 
I 
I I I I 1 
0 0.1 1 10 
LPS (pg xd) 
FIG 5. Secretion of IL-8 by peripheral blood monocytes 
in non-smokers (a-) (n=4) and smokers (a-) (n=4) 
after 24 h of culture with different concentrations of LPS. 
Data are presented as mean f SE. 
i 
that smoking decreased IL-8 release by LPS-stimulated 
AM. In contrast, the amount of IL-8 secreted by peripheral 
blood monocytes was comparable in smokers and non- 
smokers. The defect in IL-8 release by smokers’ AM can 
not be explained by altered kinetics of IL-8 release. There- 
fore cigarette smoking seems to decrease IL-8 production 
by AM. The mechanism of decreased IL-8 secretion from 
smokers’ AM is unclear. Since the in vitro exposure of 
guinea-pig and human AM to the gas phase of cigarette 
smoke have been shown to decrease TNF and IL-6 produc- 
tion (32) cigarette smoke may have a direct detrimental 
effect on AM. 
Our results also showed that the IL-8 concentration in 
BALF was much higher in smokers than in non-smokers. 
One possible explanation for the elevated IL-8 concen- 
tration in BALF of smokers would be differences in the 
cellular composition of lavage. AM were found in increased 
numbers in the lungs of smokers. Therefore, impaired 
cytokine secretion by smokers’ AM appeared to be offset by 
the increased number of AM in BALF. In our studies, the 
IL-8 concentration in BALF was much higher in smokers 
than in non-smokers after correcting for cell numbers (data 
not shown). This is not surprising since IL-8 is produced by 
not only AM but other cells such as bronchial and alveolar 
epithelial cells, endothelial cells, and fibroblasts (l&20,33). 
However, most cell types other than monocytes and macro- 
phages constitutively produce only a small amount of IL-8 
(34). Recently Mio et al. (24) have demonstrated that 
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cigarette smoke extract augmented the IL-8 release from 
cultured human bronchial epithelial cells, and that IL-8 
concentrations were higher in bronchial samples of BALF 
from both non-smokers and smokers than in alveolar 
samples. They also reported that there was a significant 
correlation between neutrophil number per ml and IL-8 
concentration in the bronchial sample of BALF, whereas 
there was no significant correlation between those in 
alveolar samples. Therefore, the increased concentrations 
of IL-8 in BALF from smokers may be due to constant 
stimulation of the non-leukocytic cells, such as bronchial 
epithelial cells, in the airway by smoking. 
AM are necessary for initiating a primary immune 
response in the lung against invasion of pathogenic organ- 
isms. Decreased IL-l, TNF, IL-6, and IL-8 secretion by 
AM may result in impairment of pulmonary immune 
responses in smokers, and this may increase the incidence of 
infection on one hand and reduce the incidence of immune 
disorders such as hypersensitivity pneumonitis on the other. 
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